Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00534144 · ClinicalTrials.gov registry record · Phase 1
Comparison Between Effects of Two Iron Preparations on Protein in the Urine
A Phase 1 study, sponsored by Watson Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 74
- Enrollment target
NCT00534144 is a Phase 1 study that has completed, run by Watson Pharmaceuticals. The registered enrollment target is 74 participants.
The verdict
NCT00534144, a Phase 1 study, has completed, sponsored by Watson Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 74 participants
- Enrollment target
Study Summary
This study will compare the effects of sodium ferric gluconate complex and iron sucrose on urine concentrations of various chemicals including protein
Interventions
- DRUG iron sucrose injection, USP
- DRUG sodium ferric gluconate complex in sucrose injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2007-09 |
| Est. Completion | 2008-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00534144
The ClinicalTrials.gov registry entry for NCT00534144 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Watson Pharmaceuticals, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which iron sucrose injection, USP is the first listed.
NCT00534144 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00534144 about?
NCT00534144 is a clinical study titled "Comparison Between Effects of Two Iron Preparations on Protein in the Urine". This study will compare the effects of sodium ferric gluconate complex and iron sucrose on urine concentrations of various chemicals including protein
What is the current status of trial NCT00534144?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 74 participants. The study started on 2007-09. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00534144?
The interventions under investigation include: iron sucrose injection, USP (DRUG), sodium ferric gluconate complex in sucrose injection (DRUG).
Who is sponsoring clinical trial NCT00534144?
This trial is sponsored by Watson Pharmaceuticals, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.